Willis Johnson & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Sell |
1,844
-1,413
| -43% | -$262K | 0.02% | 116 |
|
|
2025
Q1 | $682K | Sell |
3,257
-122
| -4% | -$25.6K | 0.05% | 76 |
|
|
2024
Q4 | $600K | Buy |
3,379
+291
| +9% | +$51.7K | 0.05% | 85 |
|
|
2024
Q3 | $610K | Sell |
3,088
-100
| -3% | -$19.8K | 0.05% | 86 |
|
|
2024
Q2 | $547K | Sell |
3,188
-79
| -2% | -$13.5K | 0.04% | 87 |
|
|
2024
Q1 | $595K | Sell |
3,267
-11
| -0.3% | -$2K | 0.05% | 77 |
|
|
2023
Q4 | $508K | Buy |
3,278
+51
| +2% | +$7.9K | 0.05% | 75 |
|
|
2023
Q3 | $481K | Buy |
3,227
+825
| +34% | +$123K | 0.05% | 76 |
|
|
2023
Q2 | $324K | Sell |
2,402
-35
| -1% | -$4.72K | 0.03% | 96 |
|
|
2023
Q1 | $388K | Buy |
2,437
+127
| +5% | +$20.2K | 0.05% | 85 |
|
|
2022
Q4 | $373K | Sell |
2,310
-363
| -14% | -$58.7K | 0.05% | 80 |
|
|
2022
Q3 | $359K | Sell |
2,673
-343
| -11% | -$46.1K | 0.05% | 77 |
|
|
2022
Q2 | $462K | Sell |
3,016
-108
| -3% | -$16.5K | 0.06% | 72 |
|
|
2022
Q1 | $506K | Buy |
3,124
+788
| +34% | +$128K | 0.07% | 67 |
|
|
2021
Q4 | $316K | Buy |
2,336
+281
| +14% | +$38K | 0.04% | 77 |
|
|
2021
Q3 | $222K | Sell |
2,055
-173
| -8% | -$18.7K | 0.03% | 85 |
|
|
2021
Q2 | $251K | Buy |
2,228
+49
| +2% | +$5.52K | 0.04% | 77 |
|
|
2021
Q1 | $236K | Buy |
+2,179
| New | +$236K | 0.04% | 79 |
|